What is discogenic low back pain and what are the recommended management steps?

Discogenic Low Back Pain: Definition and Management

Discogenic low back pain (DLBP) is chronic axial low back pain originating from internal disc disruption—specifically annular fissures, endplate inflammation, and abnormal nerve ingrowth into the degenerated disc—and the most recent 2025 BMJ guideline strongly recommends AGAINST epidural injections for this condition, while supporting basivertebral nerve ablation as the primary interventional option for refractory cases. 1

What is Discogenic Low Back Pain?

DLBP results from a pathophysiologic "triad" of disc degeneration: structural damage (annular tears, fissures), functional impairment (loss of disc height and pressure distribution), and metabolic dysregulation (inflammation, abnormal nerve and blood vessel ingrowth into normally aneural disc tissue) 2. The disc becomes a pain generator through:

• Annular fissures allowing inflammatory mediators to leak and sensitize nerve endings
• Endplate inflammation visible as Modic changes on MRI
• Neovascularization and neoinnervation of the inner annulus, creating new pain pathways 3

This differs from radicular pain (nerve root compression) or facet-mediated pain—DLBP is axial, midline low back pain without significant leg symptoms.

Clinical Recognition

Look for this specific constellation 2, 4:

• Axial midline back pain ≥4/10 in intensity
• Sitting intolerance and pain worsened by flexion
• Positive sustained hip flexion test (reproduces familiar pain)
• Absence of motor, sensory, or reflex changes (rules out radiculopathy)
• Non-radicular pain referral to buttocks or posterior thigh without dermatomal pattern
• Pain centralization with extension-based movements

Diagnostic Approach

MRI is the primary imaging modality to identify structural disc pathology and rule out other causes 4:

• High-intensity zones (HIZ) in the posterior annulus suggest annular tears
• Modic changes (Types 1,2, or 3) indicate endplate inflammation or degeneration
• Modified Pfirrmann grading (1-8) stratifies degeneration severity
• Disc height loss and dehydration on T2-weighted sequences

Provocative discography remains the diagnostic standard when imaging is equivocal, reproducing concordant pain at low pressure in the suspected disc while control levels remain negative 5, 6. However, this is controversial due to potential acceleration of disc degeneration with needle insertion 7.

Critical caveat: Degenerative disc findings are extremely common in asymptomatic individuals—diagnosis requires level-concordant imaging findings matching clinical presentation 6.

Management Algorithm

Step 1: Conservative Management (First-Line, 8-12 weeks)

• Structured exercise therapy emphasizing core stabilization and McKenzie-based extension exercises
• Remain active—bed rest is contraindicated 8
• NSAIDs for short-term pain control
• Multidisciplinary biopsychosocial rehabilitation (moderate evidence) 9
• Self-care education using evidence-based resources
• Heat application for acute flares 8

Step 2: Functional Myofascial Assessment and Treatment

If conservative care fails, assess for concurrent myofascial or thoracolumbar fascial dysfunction that may amplify disc-related pain 2:

• Ultrasound-guided dry needling of myofascial trigger points as an intermediate functional intervention
• This addresses the functional modifier component before escalating to ablative procedures

Step 3: Phenotype-Specific Interventional Procedures (Refractory Cases)

The 2025 BMJ guideline provides strong recommendations AGAINST several commonly used interventions for chronic axial spine pain 1:

DO NOT OFFER:

• Epidural injections of local anesthetic, steroids, or their combination
• Facet joint injections or radiofrequency ablation (these target facet-mediated pain, not discogenic pain)
• Intramuscular injections with or without steroids

SUPPORTED INTERVENTIONS (based on phenotype):

Vertebrogenic DLBP (Modic changes, endplate inflammation):

• Basivertebral nerve (BVN) ablation receives strong recommendation 1, 2
• Targets the nerve supplying the vertebral endplate
• Appropriate for Modic Type 1 or 2 changes

Annulogenic DLBP (annular fissures with HIZ):

• Bipolar cooled radiofrequency ablation (biacuplasty) 2, 5
• Targets the posterior annulus where fissures and nerve ingrowth occur
• Limited but emerging evidence

Mixed DLBP (concurrent endplate and annular pathology):

• May require combined denervation strategies 2

Neuro-sensitized DLBP (central sensitization dominant):

• Spinal cord stimulation or dorsal root ganglion stimulation as salvage options 5

Step 4: Surgical Consideration (Grade 8 Degeneration)

For severe, refractory cases with advanced degeneration:

• Spinal fusion or artificial disc replacement
• Evidence shows no superiority over multidisciplinary rehabilitation 9
• Reserve for carefully selected patients after exhausting conservative and interventional options

Critical Guideline Conflicts

Major divergence exists between recent guidelines:

• 2025 BMJ guideline (most recent, highest quality): Strong recommendation AGAINST epidural injections for chronic axial spine pain 1
• 2022 ASPN guideline: Strong recommendation FOR epidural injections for disc disease 1
• 2021 ASIPP guideline: Moderate to strong recommendation FOR epidural injections for axial discogenic pain 1
• 2020 NICE guideline: Do NOT offer spinal injections for low back pain 1

The 2025 BMJ guideline should take precedence as the most recent, published in the highest-impact journal, and based on comprehensive systematic review showing epidural injections provide minimal benefit for axial pain while carrying risks of infection, altered consciousness, and rare catastrophic complications including paralysis and death 1.

Emerging Regenerative Therapies

Intradiscal platelet-rich plasma (PRP) and pulsed radiofrequency (PRF) show promise but have insufficient long-term data 7. Major concern: needle insertion accelerates disc degeneration, especially with larger needles or repeated procedures 7. If considering these, limit to one or two procedures maximum using thin needles 7.

Mesenchymal stem cell injections remain investigational with limited evidence 5.

Common Pitfalls

• Over-reliance on MRI findings alone—disc degeneration is ubiquitous in aging populations and does not confirm pain source
• Offering epidural injections for axial discogenic pain—these are ineffective and potentially harmful for non-radicular pain 1
• Premature surgical referral—fusion shows no superiority to structured rehabilitation 9
• Ignoring concurrent myofascial dysfunction—this functional component may be more amenable to treatment than the structural disc pathology 2